Recently launched ELUXEO® 8000 Endoscopic Imaging System with enhanced LED multi-light technology will be demonstrated, alongside expanded scope lineup and EUS offering
LEXINGTON, Mass.: FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, and the pioneer of endoscopic LED multi-light technology in the US, will showcase how it's leading the way in endoscopic imaging innovation at the upcoming 2026 Digestive Disease Week (DDW®) annual meeting, held May 3-5 in Chicago, IL. Fujifilm’s recently launched ELUXEO® 8000 Endoscopic Imaging System will make its first DDW debut offering attendees an opportunity to experience the system firsthand, as well as over a dozen state-of-the-art, 800 series scopes that are assisting physicians in upper endoscopy, colonoscopy, third space endoscopy, and ESD procedures.
“At Fujifilm, breaking barriers in innovation and providing reliable service is at the core of everything we do - and our latest endoscopic technologies reflect our commitment to pushing the boundaries of what’s possible,” says Tai Fujita, Senior Vice President, Endoscopy Division, FUJIFILM Healthcare Americas Corporation. “We’re looking forward to meeting with endoscopists and other industry leaders at DDW to give them a firsthand look on how our pioneering endoscopic imaging and supporting technologies are playing a vital role in supporting patient care and quality of life across the world.”
At booth #4631, Fujifilm will be shining a light on the following endoscopic imaging solutions:
- ELUXEO 8000 Endoscopic Imaging System: A space-saving, single-unit processor and light source, the system boasts numerous features that enhance image quality, therapeutic capabilities, and workflow efficiencies. The ELUXEO 8000 delivers unparalleled visualization through 4K resolution, Multi-LED illumination, Triple Noise Reduction technology (3NR) for advanced image clarity, and extended dynamic range to illuminate the entire field of view. In addition to Fujifilm’s clinically-proven light modes delivering enhanced polyp detection and characterization capabilities, Fujifilm developed a new, proprietary light mode for ELUXEO 8000- Amber-Red Color Imaging (ACI). ACI supports detection of bleed sources and enhances noninvasive third space endoscopy treatment with improved visualization of blood vessels and tissue layers in the submucosal space.
i>“Fujifilm's ACI mode is a game-changer for trainees and doctors learning third space procedures,” said Jennifer Phan, MD Medical Director, Director of Bariatric Endoscopy, Hoag Irvine Advanced Endoscopy Center Program Director Advanced Endoscopy Fellowship. “By enhancing red tones for blood vessels while keeping the submucosa distinctly blue, it provides noticeable clarity in differentiating the mucosa, submucosa, and muscle layers - minimizing the risk of errors such as inadvertent muscle injury, being able to easily identify the planes, and enabling safer, more efficient hands-on learning without constant light mode switching."
- 800 Series Scopes for Upper Endoscopy: Fujifilm’s expanded 800 series endoscope lineup features the latest CMOS Image Sensor technology with improved signal-to-noise ratio for high resolution and optimal brightness throughout the entire field of view. At DDW, Fujifilm will be highlighting three of its new advanced models, including:
- The EG-840T, a scope featuring a large 3.2mm working channel, 210° up angulation and increased 160° downward angulation
- The highly innovative EG-840TP ultra slim therapeutic gastroscope that combines a slim 7.9mm outer diameter with a 3.2mm working channel, as well as offering 210 up angulation and increased 160 downward angulation
- The EG-860R scope, which is designed to deliver best-in-class image clarity and enhanced down angulation of 120° for superior maneuverability
- 800 Series Colonoscopes: Fujifilm’s colonoscopes are newly equipped with state-of-the-art light sensitive CMOS sensor, providing high-definition image quality with lower noise. Additionally, the colonoscopes are equipped with a new insertion tube that enables easier insertion and enhanced maneuverability.
- Award Winning, EN-840T Double Balloon Enteroscopy Scope: Selected as the winner of the “Best New Endoscopy Technology Solution” award in the 9th annual MedTech Breakthrough Awards program, the EN-840T DBE scope features several compelling features, including its ability to allow for blood or mucus to be aspirated while a therapeutic device is inserted, enabling quicker hemostasis. The scope also provides a dedicated forward water jet channel for irrigation and enables clinicians to quickly clear debris like blood on the mucous membranes for clearer visualization of the bowel wall.
- Latest Software for the ARIETTA 850: Fujifilm is pleased to announce availability of their latest software for the ARIETTA 850. Recognized as the leader in endoscopic ultrasound imaging, this new software provides B mode image quality improvements, DFI Wall Motion Reduction PLUS as well as introduces endoscopic adaptation for Shear Wave Elastography and iATT (Attenuation Measurement) for endohepatology applications.
Also at Fujifilm’s booth, six distinguished endoscopists from renowned facilities will deliver exciting and informative ‘TECH Talk’ presentations, highlighting how the latest endoscopic innovation is helping to advance patient care:
- Sherif Andrawes, MD, FACG, NYSGEF, Chief, Division of Gastroenterology, Hepatology & Nutrition, Advanced Therapeutic & Interventional Endoscopist, Director of Advanced Therapeutic Endoscopy Fellowship, Staten Island University Hospital, Northwell Health and Robert Bechara, MD, Gastroenterologist & Advanced Therapeutic Endoscopist, Kingston Health Sciences Centre will present “Increasing Confidence in Advanced Resection: Employing Technology to Master Optical Diagnosis & Reduce Stress in Complex Cases” on Sunday, May 3, 11am CDT
- Raman Muthusamy, MD, MAS, Medical Director of Endoscopy, UCLA Health, will address “Detecting Dysplasia in Barrett’s Esophagus” on Sunday, May 3, 1:00pm CDT
- Ken Chang, MD, MASGE, AGAF, FACG, FJGES, FAFS, Executive Medical Director, Hoag Digestive Health Institute, will discuss “A New Lens on Liver Disease: The Rise of Endo-Hepatology-14 Years In” on Monday, May 4, 11am CDT
- A. Azziz Aadam, MD, Director of Interventional Endoscopy, Medical Director Global Services, Associate Professor of Medicine, Division of Gastroenterology and Hepatology, Northwestern Medicine will present, “The Next Generation of Third Space: Slim Scopes & Sharp Image” on Monday, May 4, 1:00pm CDT
- Matheus Franco, MD, MBA, MSc, PhD, Director of Endoscopy, Third Space and Bariatric Endoscopy, Associate Professor of Medicine, University of Texas at San Antonio, will discuss “From Magnifying Chromoendoscopy to Clinical Decision-Making: Managing Colorectal Polyps with Confidence” on Tuesday, May 5, 11:00am CDT
Learn how Fujifilm is leading the way in endoscopic imaging innovation by booking your demonstration with the company’s experts at DDW here.
About Fujifilm
FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company that has an extensive range of technology and expertise in the detection, diagnosis, and treatment of diseases. Fujifilm’s innovative portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The Non-Destructive Testing group delivers radiography solutions to ensure high accuracy inspection of transportation infrastructure, and assets within aerospace, and oil and gas industries.
The company is headquartered in Lexington, Massachusetts. For more information on healthcare offerings, please visit healthcaresolutions-us.fujifilm.com, and for NDT portfolio, please visit https://www.fujifilm.com/us/en/business/industrial-materials/non-destructive-testing.
FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: www.fujifilmholdings.com.
Fonte: Business Wire